Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alcon
MedTech
Alcon, Lensar drop $356M deal after black eye from FTC
The FTC threatened to challenge the deal that would have seen Alcon acquire Lensar’s robotic laser systems for cataract surgery.
Conor Hale
Mar 17, 2026 11:00am
Staar Surgical's takeover saga ends as Alcon terminates deal
Jan 7, 2026 8:00am
Alcon sees Staar Surgical for $1.5B deal
Aug 5, 2025 11:00am
Alcon to buy LumiThera’s light-based therapy for dry AMD
Jul 8, 2025 10:30am
Yet another exec departs CRISPR Tx—Chutes & Ladders
Mar 28, 2025 8:30am
Alcon gains majority stake in Aurion after power struggle
Mar 27, 2025 9:23am
